8th International Conference on Parkinsons and Movement Disorders June 03-04, 2020 Vienna, Austria
Pulsus group welcomes you to take part in the ‘ Eighth International Conference on Parkinsons and Movement Disorders” (Parkinsons 2020)’ during June 03-04, 2020 in Vienna, Austria. Which conveys the theme ” Explore the appropriate remedies for Parkinsons and Movement Disorders “.
This Parkinsons 2020 is intended to unite top pioneers and scientists on one phase going about as methods for dispersing peer-reviewed and the front line looks into information covering the entire field to the nervous system science network around the world. Generally, the outcome will be an excellent experience where the best substance on the most significant points is exhibited by pioneers with serious talks, organized in an agreeable domain expected to help a lot of systems administration and learning as could be expected.
With its logical sessions, you are given confirmation to investigate the most recent advances and leaps forward that are explicit to your area of work.
Why to Attend:
We attempt to make 8th International Conference on Parkinsons and Movement Disorders a fantastic achievement, with quality talks from neurologist and backing from the neuroscience panels and affiliations. We guarantee you that you will encounter world class offices and hospitability throughout the gathering. With people from around the world concentrated on increasing some learning its advances, this is your definitive open door at Parkinsons 2020. Prestigious speakers, the most recent methods, specialists, in neuroscience indicate this gathering. The members can discover specific sessions and talks on latest advancements in Neuroscience and Neurological Disorders by
Talks from Well-known speakers
Keynote gatherings by eminent professors, master specialists
Open advancement challenges
Poster Presentation by youthful analysts
Novel systems to profit your exploration
Best stage for worldwide business and systems administration openings
Astounding stage to exhibit the most recent products and plans in the field of neuroscience
Target Audience:
Neurologists, Neurosurgeons, Directors, Deans, Doctors, Psychiatrists, psychologists, University professors, Nurses, Therapists, Various societies and their members, Institutes-Medical schools students, Research scholars, Business entrepreneurs, Training Institutes, Manufacturing medical devices companies.
Market Analysis
Parkinson’s disease is a progressive nervous system condition characterized by tremor, muscle stiffness, and mild, imprecise movement, which mainly affects the elderly and adults. It is linked to brain basal ganglia degeneration and neurotransmitter dopamine deficiency.
It has been observed that dopamine – producing cells known as dopaminergic neurons in the substantia nigra part of the brain – has died according to neurological studies to date that showed that dopamine a neurotransmitter in the brain gradually lowered its rate and that contributes to Parkinson’s disease. The progressive nervous system condition influences the movement of people, such as speaking, writing, walking and other voluntary activities, using various treatments for Parkinson’s disease but still raising the death rate of Parkinson’s disease.
The condition of Parkinson is a progressive neurological disorder caused by neurodegeneration. Approximately 10 million people worldwide suffer from Parkinson’s disease. In 2012, the global prevalence was about 2.18 million cases worldwide where the US market had $1.15 billion. The Parkinson’s disease market in the US is expected to rise from $1.1 billion in sales in 2012 to $2.3 billion in 2022 at a rate of 7.3 percent. Treatment market value is expected to rise from $3.6 billion in 2012 to $5.3 billion in 2022. The US- has the largest market share for Parkinson’s clinical disease of 44% by 2022, which is rising from 32% in 2012, led by Japan, Brazil and Germany with 13%, 11% and 10%. Approximately 1 million people in the US have Parkinson’s disease, 60,000 of which have been diagnosed annually. Around 127,000 people suffer from PD in the United Kingdom. Male has 50% higher risk than females, but 4 to 5% of patient cases are younger than 40 years and it is known as Parkinson’s disease Young-onset.
Major Associations around the globe:
- National Parkinson Foundation
- American Parkinson Disease Association (APDA)
- Parkinson’s disease Foundation
- Movement Disorder Society of Australia
- Parkinson’s Unity Walk
- Movement Disorder Society of Japan
- Moroccan Neurological Society Movement Disorders Group
- Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
- Ecuador Movement Disorders Group
- Austrian Parkinson’s Disease Society
- Danish Movement Disorder Society
- International Parkinson and Movement Disorder Society
Top universities globally working in the field of Parkinson Disease
- University of Bath
- The University of Queensland
- University of Bristol
- University of Cambridge
- The Imperial College of Science and Medicine
- Duke University
- University of Milan
- Karolinska Institute
- University of Hamburg
- The University of Edinburgh
- University of Munich
- University of Rochester
- University of Zurich
- Leiden University
- University of Bristol
- University of Helsinki
- University of Freiburg
- University of Frankfurt
Hospital Associated with Parkinson Disease:
- Royal Free Hospital
- National Hospital for Neurology and Neurosurgery
- University Hospital Coventry and Warwickshire
- St George’s Hospital Atkinson Morley Wing
- Chelsea and Westminster Hospital
- Queen Elizabeth Hospital
- The James Cook University Hospital
- John Radcliffe Hospital
For Contact and Registration:
